20 completed, 7 unknown. 27 Phase 1.
By phase and status
Follow Pharmtechnology LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions
Perindopril tablet, Prestarium® A tablet - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 50 | 2024-01-09 | 2024-01-19 |
Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions
Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 50 | 2023-06-24 | 2023-07-11 |
Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions
Clopidogrel film-coated tablet 75 mg, Plavix® film-coated tablet 75 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 60 | 2023-06-16 | 2023-11-30 |
Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions
Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg, Tritace® Plus tablet 10 mg/25 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 50 | 2022-12-28 | 2024-01-08 |
Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions
Atorvastatin film-coated tablet 40 mg, Liprimar® film-coated tablet 40 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 50 | 2022-11-19 | 2024-01-11 |
Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions
Ramipril tablet 10 mg, Tritace® tablet 10 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 50 | 2022-06-17 | 2023-06-29 |
Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Conditions
Aceclofenac film-coated tablet 100 mg, Airtal® film-coated tablet 100 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 36 | 2022-04-15 | 2023-06-28 |
Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions
Lisinopril tablet 20 mg, Zestril® tablet 20 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 38 | 2021-10-06 | 2022-07-07 |
Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions
Torasemide tablet 10 mg, Toradiur® tablet 10 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 26 | 2021-06-05 | 2023-06-29 |
Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions
Sildenafil film-coated tablet 100 mg, Viagra® film-coated tablet 100 mg - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 44 | 2021-05-10 | 2021-05-12 |
Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions
Etoricoxib film-coated tablet 120 mg, Arcoxia® film-coated tablet 120 mg - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 34 | 2021-04-10 | 2021-04-05 |
Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Conditions
Rivaroxaban film-coated tablet 10 mg, Xarelto® film-coated tablet 10 mg - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 34 | 2021-02-13 | 2021-02-15 |
Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions
Rivaroxaban film-coated tablet 20 mg, Xarelto® film-coated tablet 20 mg - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 34 | 2021-01-30 | 2021-01-29 |
A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use, Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 32 | 2019-10-31 | 2019-12-03 |
Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions
Fluconazole, Diflucan® - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 26 | 2019-07-26 | 2023-11-30 |
The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions
Candesartan Cilexetil 32mg, Atacand® PROTECT - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 40 | 2019-07-11 | 2019-11-18 |
The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.
Olmesartan Medoxomil 40 mg, Olmetec® - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 32 | 2019-05-06 | 2019-07-29 |
Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions
Febuxostat, Adenuric - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 50 | 2019-05-03 | 2019-07-08 |
A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions
Lamotrigine, Lamictal - Healthy Adults | Phase 1 | Completed | Pharmtechnology LLC | 28 | 2019-03-23 | 2019-06-06 |
Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions
Montelukast, Singulair - Healthy Adults | Phase 1 | Completed | Pharmtechnology LLC | 34 | 2019-03-23 | 2019-06-06 |
Showing 20 of 27. Sign in to see all of them.
Interventions
Tablets (3) · Amoxicillin-Potassium Clavulanate Combination (2) · Hydrochlorothiazide (2) · Olmesartan Medoxomil (2) · Perindopril (2) · Ramipril (2) · Amlodipine (1) · Febuxostat (1) · Fluconazole (1) · Indapamide (1) · Lamotrigine (1) · Lisinopril (1) · Losartan (1) · Propafenone (1) · Sotalol (1)
Countries
Russia (18) · Canada (7) · Belarus (1) · India (1)
Top investigators
Alexander Khokhlov (8) · Eric Sicard, MD (7) · Alexander Khokhlov, Professor (3) · Irina Rodyukova (2) · Sergey Filatov (2) · Anastasia Teteryukova, MD (1) · Evgenia Simonova (1) · Irina Rodiukova (1) · Natalia Moshnikova (1) · Suresh A Maroli, MD (1)